ARTICLE | Company News
FDA approves SeroJet
March 28, 2001 8:00 AM UTC
The FDA approved SeroJet, a needle free device developed by Serono (SRA; SWX:SEO) and Bioject (BJCT). SeroJet provides needle free subcutaneous delivery of Serostim, SRA's recombinant human growth hor...